Teresa L. Wright, Harry Hollander, Xiang Pu, Michael J. Held, Peter Lipson, Stella Quan, Alan Polito, M. Michael Thaler, Peter Bacchetti, Bruce F. Scharschmidt – 1 November 1994 – Background: Limited information is available about the prevalence of hepatitis C virus in patients with human immunodeficiency virus in relation to specific risk factors or about the influence of hepatitis C virus coinfection on survival. This retrospective study addressed these questions.

Satoshi Ishiguro, Shigeki Arii, Kazunobu Monden, Yukito Adachi, Naomi Funaki, Hiroaki Higashitsuji, Shin‐Ichi Fujita, Masaharu Furutani, Masahiro Mise, Tadahiro Kitao, Toshio Nakamura, Fumitaka Ushikubi, Ken‐Ichi Nakamura, Shuh Narumiya, Katsuhiko Enomoto, Tousei Ohmura, Michio Mori, Masayuki Imamura – 1 November 1994 – The presence of the thromboxane A2 receptor in sinusoidal endothelial cells was investigated and its pathogenic role in endotoxin‐induced liver injury examined. The receptor was measured with a binding assay using a specific thromboxane A2 receptor antagonist, [3H]S‐145.

Jurgen Ludwig, Charles B. Rosen, Keith D. Lindor, John H. Helzberg, Kenneth R. Watson – 1 November 1994

William J. Parks – 1 November 1994

Shuichi Hanada, Takaji Wakita, Hiroshi Takahashi – 1 November 1994 – Fusion of BERH‐2 rat hepatocellular carcinoma cells with activated B cells produced hybrid cells that lost their tumorigenicity and became immunogenic. Syngeneic rats injected with BERH‐2‐B hybrid cells became resistant to challenge with parental BERH‐2 cells, and rats with established BERH‐2 hepatomas were cured by subsequent injection of BERH‐2‐B cells. Both CD4 and CD8+ cells were essential for the induction of protective immunity; however, only CD8+ cells were required for the eradication of BERH‐2 tumors.

Jon W. Gordon – 1 November 1994

Charles M. Noyer, Howard J. Worman – 1 November 1994

Hiroaki Okamoto, Shunji Mishiro, Hajime Tokita, Fumio Tsuda, Yuzo Miyakawa, Makoto Mayumi – 1 November 1994 – Three chimpanzees persistently infected with hepatitis C virus of genotype II/1b were challenged with hepatitis C virus of genotype III/2a and 6 wk later with hepatitis C virus of genotype I/1a. They were tested for titers of total and genotype‐specific hepatitis C virus RNA, as well as for serum transaminase levels, until 52 wk after the first challenge.

Masao Honda, Shuichi Kaneko, Akito Sakai, Masashi Unoura, Seishi Murakami, Kenichi Kobayashi – 1 November 1994 – We examined the quasispecies of the hepatitis C virus genome in 28 patients with liver disease of varying severity.

Andrés C. Inglés, Dallas J. Legare, W. Wayne Lautt – 1 November 1994 – A model of prehepatic chronic portal hypertension in cats was used to determine portacaval shunt responses to infused norepinephrine and to possible transmitter overflow into portal blood from nerves supplying the gut. Responses are compared using a new index of contractility. Four weeks after application of a slowly constricting occluder, the portal vein was completely occluded and acute experiments were carried out under pentobarbital anesthesia.